Exagen Inc.
XGN- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001274737
In the last 90 days, Exagen Inc. insiders filed 0 open-market purchases and 1 sale; 57 institutions reported holding it in 13F filings for Q2 2026, worth $37.0M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Exagen Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 38 | 31 | −7 |
| Shares | 7.93M | 6.94M | −994.4K (−12.5%) |
| Value | $21.4M | $16.6M | −$4.80M (−22.4%) |
New holders (3)
Institutions that held Exagen Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Credit Suisse AG | 5,000 | $12.0K | 0.00% |
| Simplex Trading, LLC | 547 | $1.00K | 0.00% |
| GWM Advisors LLC | 245 | $588 | 0.00% |
Sold out (10)
Institutions that held Exagen Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Brinker Capital Investments, LLC | 99,115 | $269.0K |
| Paradigm Capital Management Inc | 81,189 | $220.0K |
| Advisors Capital Management, LLC | 67,923 | $143.0K |
| Deutsche Bank AG | 50,660 | $137.0K |
| Ergoteles LLC | 48,558 | $132.0K |
| Envestnet Asset Management Inc | 23,665 | $64.0K |
| Parallel Advisors, LLC | 4,213 | $11.0K |
| First Horizon Advisors, Inc. | 1,378 | $3.00K |
| Cowen Prime Advisors LLC | 500 | $1.00K |
| BNP Paribas Arbitrage, SA | 169 | $458 |